FDA Adverse Event Injury Summary report: N

M-VIZION FEMORAL REVISION SYSTEM

MDR report key: 23477198 · Received November 5, 2025

Report

Report Number
3005180920-2025-01063
Event Type
Injury
Date Received
November 5, 2025
Date of Event
October 14, 2025
Report Date
November 5, 2025
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
LZO
UDI-DI
07630030885037
PMA / PMN Number
K170690
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 17 OCTOBER 2025. STEM: M-VIZION 01.22.106 DISTAL STEM Ø17MM L 140MM STRAIGHT LOT. 2101129 (K170690): (B)(4) ITEMS MANUFACTURED AND RELEASED ON 23-JULY-2021. EXPIRATION DATE: 2026-07-12. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENTS DURING THE PERIOD OF REVIEW. STEM: M-VIZION 01.22.401 PROXIMAL BODY Ø20MM L 40MM STD WITH HOLES LOT. 2247722 (K170690) LOT 2247722: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 29-MARCH-2023. EXPIRATION DATE: 2028-03-12. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENTS DURING THE PERIOD OF REVIEW. ROOT CAUSE: BASED ON THE INFORMATION AVAILABLE NO DEFINITIVE ROOT CAUSE CAN BE ESTABLISHED, ALTHOUGH IT IS POSSIBLE THAT FACTORS SUCH AS LOW BONE QUALITY MAY HAVE CONTRIBUTED TO THE EVENT. ALTHOUGH NO ROOT CAUSE CAN BE CONFIRMED, THE INVESTIGATION DOES NOT INDICATE ANY POTENTIAL MANUFACTURING RELATED ISSUE OR SYSTEMIC DEFICIENCY.

Description of Event or Problem · 0

AT ABOUT 1 YEAR 8 MONTHS AFTER THE PRIMARY, THE PATIENT CAME IN REPORTING PAIN DUE TO A SUBSIDED STEM AND THE CAUSE IS UNKNOWN. THE SURGEON REVISED THE STEM AND HEAD AND THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2491519 M-VIZION FEMORAL REVISION SYSTEM DISTAL STEM Ø17MM L 140MM STRAIGHT LZO MEDACTA INTERNATIONAL SA 01.22.106 2101129 07630030885037

Patients

Seq Age Sex Outcome Treatment
1 NA Female Required Intervention